Detection and treatment of prostate cancer

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007100, C435S004000, C530S388800

Reexamination Certificate

active

07135301

ABSTRACT:
An antigen is shown to be associated with prostate cancer, and is useful for new methods and compositions for diagnosing or treating prostate cancer. This is particularly useful for individuals with prostate cancer who test negative for Prostate Specific Antigen. Additionally, this is useful for distinguishing between benign prostate disease and prostate cancer in a patient diagnosed or presenting with prostate dysfunction.

REFERENCES:
patent: 4863713 (1989-09-01), Goodwin et al.
patent: 5227160 (1993-07-01), Nudelman et al.
patent: WO 97/03701 (1997-02-01), None
Tsuji et al. J. Exp. Med. 1988,168: 343-356.
Nudelman et al., J Biol Chem 1989, 264: 18719-18725).
Fundamental Immunology p. 242,William E. Paul, M.D. ed., 3d ed. 1993.
Nudelman et al. (JBC 1989; 264: 18719-18725).
Itai et al., “Differentiation-dependent Expression of 1 and Sialyl 1 Antigens in the Developing Lung of Human Embryos and in Lung Cancers,”Cancer Res. 50:7603-7611, Dec. 1, 1990.
Nudelman et al., “A Series of Disialogangliosides with Binary 2→3 Sialyllactosamine Structure, Defined by Monoclonal Antibody NUH2, Are Oncodevelopmentally Regulated Antigens,”J.Biol. Chem. 284(31): 18719-18725, Nov. 5, 1989.
Kannagi et al, “Quantitative and Qualitative Characterization of Human Cancer-associated Serum Glycoprotein Antigens Expressing Fucosyl or Sialyl-Fucosyl Type 2 Chain Polylactosamine,”Cancer Res. 46:2619-2626, 1986.
Laganà, A. et al., “Determination of serum total lipid and freeN-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of freeN-acetylneuraminic acid as tumour marker,”Clinica Chimica Acta 243:165-179, 1995.
Satoh, M. et al., “Glycolipid Expression in Prostatic Tissue and Analysis of the Antigen Recognized by Antiprostatic Monoclonal Antibody APG1,”Urol. Int. 48: 20-24, 1992.
Shiraishi, T. et al., “The glycosphingolipids of human prostate tissue,”Biochimica et Biohphysica Acta 961: 160-169, 1988.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Detection and treatment of prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Detection and treatment of prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection and treatment of prostate cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3648335

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.